Lewis H. Bender, Chief Executive Officer at INTERLEUKIN GENETICS INC (ILI), bought 30,000 shares at $0.24 ($8K) on 2008-11-24, disclosed to the SEC on 2008-11-24.
Open-market purchase of $8k ILI by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.27 | 10,000 | $3K | 35.1% |
| 2 | $0.24 | 100 | $24 | 0.3% |
| 3 | $0.25 | 4,500 | $1K | 14.6% |
| 4 | $0.25 | 15,400 | $4K | 50.0% |
| Total | $0.26 avg | 30,000 | $8K | 100% |
| Filing → |